COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,794 Articles (22,527 medRxiv, 8,267 bioRxiv)

Most recent first Previous |  Page 162: Articles 1611-1620  | Next

Advancing Sewage Sample Surveillance with OmiCrisp: A CRISPR-Based Platform for Variant-Specific SARS-CoV-2 Detection
Arora, R., B S, K., Roy, B., Shridhar, V., Gupta, V., Chandru, V.
10.1101/2024.05.28.24307854 — Posted: 2024-05-28
Effective real-time transmission estimations incorporating population viral load distributions amid SARS-CoV-2 variants and pre-existing immunity
Meng, Y., Lin, Y., Xiong, W., Lau, E. H. Y., Ho, F., Wong, J. Y., Wu, P., Tsang, T. K., Cowling, B. J., Yang, B.
10.1101/2024.05.27.24307968 — Posted: 2024-05-27
Cell-free synthesis and purification of recombinant nucleocapsid (N), membrane (M), and envelope (E) proteins
Wang, L., Fei, M., Zhang, W., Lin, S., Jiang, Z., Zhang, S., Wang, Y.
10.1101/2024.05.24.595851 — Posted: 2024-05-27
Physiological modeling and biomechanical insights of cytokine modulation in COVID-19 and pulmonary fibrosis through graph-based approach
Ray, R., Bhowmik, R., Shyamal, S. S., Manaithiya, A., Gong, W., Parkkila, S., Aspatwar, A.
10.1101/2024.05.26.595932 — Posted: 2024-05-27
Estimating Re and overdispersion in secondary cases from the size of identical sequence clusters of SARS-CoV-2
Hodcroft, E. B., Wohlfender, M. S., Neher, R. A., Riou, J., Althaus, C. L.
10.1101/2024.05.26.24307940 — Posted: 2024-05-27
The hyperphosphorylation of SARS-CoV-2s nucleocapsid protein by GSK-3 involves a complex and redundant priming mechanism
Chen, S., He, Z., Kanyo, J., Lam, T., Ha, G., Lindenbach, B. D. D., Ha, Y.
10.1101/2024.05.25.595913 — Posted: 2024-05-27
Fine-scale spatial and social patterns of SARS-CoV-2 transmission from identical pathogen sequences
Tran-Kiem, C., Paredes, M. I., Perofsky, A. C., Frisbie, L. A., Xie, H., Kong, K., Weixler, A., Greninger, A. L., Roychoudhury, P., Peterson, J. M., Delgado, A., Holstead, H., MacKellar, D., Dykema, P., Gamboa, L., Frazar, C. D., Ryke, E., Stone, J., Reinhart, D., Starita, L., Thibodeau, A., Yun, C., Aragona, F., Black, A., Viboud, C., Bedford, T.
10.1101/2024.05.24.24307811 — Posted: 2024-05-25
Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby, P. W., Staplin, N., Peto, L., Emberson, J. R., Campbell, M., Pessoa-Amorim, G., Basnyat, B., Thwaites, L., Van Doorn, R., Hamers, R. L., Nel, J., Amuasi, J., Stewart, R., Ghosh, D., Hamilton, F., Desai, P., Easom, N., Majumdar, J., Hine, P., Chadwick, D., Cooke, G., Sharp, S., Esmail, H., Baillie, J. K., Buch, M. H., Faust, S. N., Jaki, T., Jeffery, K., Juszczak, E., Knight, M., Lim, W. S., Montgomery, A., Mukherjee, A., Mumford, A., Rowan, K., Thwaites, G., Mafham, M., Haynes, R., Landray, M. J.
10.1101/2024.05.23.24307731 — Posted: 2024-05-24
Detection of anti-nucleocapsid antibodies associated with primary SARS-CoV-2 infection in unvaccinated and vaccinated blood donors
Grebe, E., Stone, M., Spencer, B. R., Akinseye, A., Wright, D., Di Germanio, C., Bruhn, R., Zurita, K. G., Contestable, P., Green, V., Lanteri, M. C., Saa, P., Biggerstaff, B. J., Coughlin, M. M., Kleinman, S., Custer, B., Jones, J. M., Busch, M. P.
10.1101/2024.05.23.24307822 — Posted: 2024-05-24
Effects of the COVID-19 pandemic on individuals with Chemical Intolerance
Palmer, R. F., Kattari, D., Verduzco-Gutierrez, M.
10.1101/2024.05.23.24307835 — Posted: 2024-05-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).